Abstract
Bifidobacteria are the predominant bacteria in the gastrointestinal tract of an infant. The colonization pattern of the bifidobacteria is affected by mode of delivery and types of feeding. Newborns from vaginal delivery are firstly exposed to maternal vaginal, fecal, and skin bacteria, such as Lactobacillus, Prevotella, and Atopobium. In the few days after birth, a reduced environment in the gastrointestinal tract favors the arrival and proliferation of obligate anaerobic bacteria, such as Bifidobacterium, and subsequently becomes predominant in the infant’s gastrointestinal tract. Also, in breast-fed infants, Bifidobacterium concentration is higher than formula-fed infants as human breast milk contains human milk oligosaccharides (HMOs) which are bifidobacterial growth-promoting factors. In addition to HMOs, existing lysozyme in breast milk could be involved in selection of infant-type Bifidobacterium as inhabitants of the infant intestines. Bifidobacteria colonization in infants initiates the development and maturation of the infant’s naive immune system by stimulating dendritic cells through Toll-like receptors (TLR) and leads to differentiation of naive T lymphocytes into Th1 cells by recognizing the peptidoglycans in bifidobacteria. Hence, immune response, control intestinal inflammation, and mucosal tolerance are initiated. Production of immunoglobulin A (IgA) is also stimulated by the presence of bifidobacteria to stimulate intestinal antigenic ability. Bifidobacteria are able to prevent and treat atopic diseases in infants by restoring Th1/Th2 balance and enhance the production of IFN-γ. In addition, bifidobacteria are also effective in reducing the duration of gastrointestinal diseases by modification and stabilization of GIT microflora, reduction in the duration of retrovirus shedding, reduction of GIT permeability, as well as induction of general immune response by increasing IgA antibodies. In respiratory tract infections, bifidobacteria enhance several immune responses by increasing immune cell activity, modulating signals in epithelial and immune cells, increasing local and systemic antibody production, and inducing phenotypic changes in dendritic cells. Considering that Bifidobacterium are the natural inhabitants of infant intestines, and much clinical evidence of efficacy to infants have been documented, Bifidobacterium strains are highly encouraged for use as probiotics for infants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allen SJ, Okoko B, Martinez EG, Gregorio GV, Dans LF (2009) Probiotics for treating infectious diarrhoea (Review). Cochrane Database of Systematic Reviews 1:1–72
Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B (2014) The intestinal microbiome in early life: health and disease. Front Immunol 5:427. doi:10.3389/fimmu.2014.00427
Asakuma S, Urashima T, Akahori M, Obayashi H, Nakamura T, Kimura K, Watanabe Y, Arai I, Sanai Y (2008) Variation of major neutral oligosaccharides levels in human colostrum. Eur J Clin Nutr 62:488–494
Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka M (2011) Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J Biol Chem 286(40):34583–34592
Baffoni L, Stenico V, Strahsburger E, Gaggia F, Di Gioia D, Modesto M, Mattarelli P, Biavati B (2013) Identification of species belonging to the Bifidobacterium genus by PCR-RFLP analysis of a hsp60 gene fragment. BMC Microbiol 13(149):1–9
Balamurugan R, Magne F, Balakrishnan D, Suau A, Ramani S, Kang G, Ramakrishna BS (2010) Faecal bifidobacteria in Indian neonates & the effect of asymptomatic rotavirus infection during the first month of life. Indian J Med Res 132:721–727
Bergmann KR, Liu SXL, Tian RL, Kushnir A, Turner JR, Li HL, Chou PM, Weber CR, de Plaen IG (2013) Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol 182(5):1595–1606
Bifidobacteria. (2014) [Online], [Accessed 7th April 2015]. Available from Natural Medicines Comprehensive Database: httcp://naturaldatabase.therapeuticresearch.com/nd/PrintVersion.aspx?id = 891&AspxAutoDetectCookieSupport = 1
Boesten R, Schuren F, Ben Amor K, Haarman M, Knol J, de Vos WM (2011) Bifidobacterium population analysis in the infant gut by direct mapping of genomic hybridization patterns: potential for monitoring temporal development and effects of dietary regimens. Microb Biotechnol 4:417–427
Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V (2003) Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36:775–780
Bottacini F, Ventura M, van Sinderen D, O’Connell MM (2014) Diversity, ecology and intestinal function of bifidobacteria. Microb Cell Factories 13:1–15
Boyle RJ, Robins-Browne RM, Tang MLK (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83:1256–1264
Carbohydrates (2015) [Online], [Accessed 4th April 2015]. Available from European Food Information Council: http://www.eufic.org/article/en/expid/basics-carbohydrates/
Chang SH, Park KY, Kang SK, Kang KS, Na SY, Yang HR, Uhm JH, Ryoo E (2013) Prevalence, clinical characteristics, and management of functional constipation at pediatric gastroenterology clinics. J Korean Med Sci 28(9):1356–1361
Clinton C (2010) Development of the infant immune function and the effects of breast milk. Nat Med J 2(8):3–6
Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A (2010) Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr 157(4):598–602
D’Aimmo MR, Modesto M, Biavati B (2007) Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. Isolated from dairy and pharmaceutical products. Int J Food Microbiol 115(1):35–42
De Bruyn F, Beauprez J, Maertens J, Soetaert W, de Mey M (2013) Unraveling the Leloir pathway of Bifidobacterium bifidum: significance of the uridylyltransferases. Appl Environ Microbiol 79(22):7028–7035
de Vrese M, Marteau PR (2007) Probiotics and prebiotics: effects on diarrhea. J Nutr 137:803S–811S
Dong P, Yang Y, Wang WP (2010) The role of intestinal bifidobacteria on immune system development in young rats. Early Hum Dev 86:51–58
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638
Enomoto T, Sowa M, Nishimori K, Shimazu S, Yoshida A, Yamada K, Furukawa F, Nakagawa T, Yanagisawa N, Iwabuchi N, Odamaki T, Abe F, Nakayama J, Xiao JZ (2014) Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int 63:575–585
Esposito S, Rigante D, Principi N (2014) Do children’s upper respiratory tract infections benefit from probiotics? BMC Infect Dis 14(194):1–7
Forchielli ML, Walker WA (2005) The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 93:41–48
Fox MJ, Ahuja KDK, Robertson IK, Ball MJ, Eri RD (2015) Can probiotic yogurt prevent diarrhea in children on antibiotics? A double-blind, randomized, placebo-controlled study. BMJ Open 5, e006474
Fujita K, Oura F, Nagamine N, Katayama T, Hiratake J, Sakata K, Kumagai H, Yamamoto K (2005) Identification and molecular cloning of a novel glycoside hydrolase family of core 1 type O-glycan-specific endo-α-N-acetylgalactosaminidase from Bifidobacterium longum. J Biol Chem 280:37415–37422
Fushinobu S (2010) Unique sugar metabolic pathways of bifidobacteria. Biosci Biotechnol Biochem 74(12):2374–2384
Gagnon M, Kheadr EE, Le Blay G, Fliss I (2004) In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. Int J Food Microbiol 92:69–78
Gerritsen J, Smidt H, Rijkers GT, de Vos WM (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6:209–240
Gill HS, Prasad J, Donkor O (2012) Probiotics and human immune function. In: Lahtinen S, Ouwehand AC, Salminen S, von Wright A (eds) Lactic acid bacteria. CRC Press, Boca Raton, FL, pp 439–508
Glendinning L, Free A (2014) Supra-organismal interactions in the human intestine. Cell Infect Microbiol 4(47):1–4
Goehring KC, Kennedy AD, Prieto PA, Buck RH (2014) Direct evidence for the presence of human milk oligosaccharides in the circulation of breastfed infants. PLoS One 9(7):1–11
Greer FR, Sicherer SH, Burks AW (2008) Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyze formulas. Pediatrics 121(1):183–191
Grimm V, Westermann C, Riedel CU (2014) Bifidobacteria-host interactions – an update on colonization factors. BioMed Res Int 2014:1–10
Grönlund MM, Gueimonde M, Laitinen K, Kociubinski G, Grönroos T, Salminen S, Isolauri E (2007) Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 37:1764–1772
Gueimonde M, Laitinen K, Salminen S, Isolauri E (2007) Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology 92:64–66
Gueimonde M, Sánchez B, de los Reyes-Gavilán CG, Margolles A (2013) Antibiotic resistance in probiotic bacteria. Front Microbiol 4(202):1–6
Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30:61–67
Hawrelak JA, Myers SP (2004) The causes of intestinal dysbiosis: a review. Altern Med Rev 9(2):180–197
Holzapfel WH (2006) Introduction to prebiotics and probiotics. In: Goktepe I, Juneja VK, Ahmedna M (eds) Probiotics in food safety and human health. CRC Press, Boca Raton, FL, pp 1–33
Horvath A, Chmielewska A, Szajewska H (2013) Functional constipation in children: a follow-up of two randomized controlled trials. Pediatr Pol 88(3):219–223
Ishibashi N, Yaeshima T, Hayasawa H (1997) Bifidobacteria: their significance in human intestinal health. Mal J Nutr 3:149–159
Jantscher-Krenn E, Bode L (2012) Human milk oligosaccharides and their potential benefits for the breast-fed neonate. Minerva Pediatr 64(1):83–99
Jungersen M, Wind A, Johansen E, Christensen JE, Stuer-Lauridsen B, Eskesen D (2014) The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12. Microorganisms 2:92–110
Kappelman MD, Grand RJ (2008) Does inflammatory bowel disease develop in infants? Inflamm Bowel Dis 14(02):S6–S8
Katayama T, Fujita K, Yamamoto K (2005) Novel bifidobacterial glycosidases acting on sugar chains of mucin glycoproteins. J Biosci Bioeng 99:457–465
Katayama T, Wada J, Fujita K, Kiyohara M, Ashida H, Yamamoto K (2008) Functions of novel glycosidases isolated from bifidobacteria. J Appl Glycosci 55:101–109
Kawasaki S (2011) Response of Bifidobacterium species to oxygen. In: Sonomoto K, Yokota A (eds) Lactic acid bacteria and bifidobacteria: current progress in advanced research. Caister Academic, Norfolk, pp 103–110
Kelly D, King T, Aminov R (2007) Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 622:58–69
Khailova L, Dvorak K, Arganbright KM, Halpern MD, Kinouchi T, Yajima M, Dvorak B (2009) Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297(5):G940–G949
Khokhlova EV, Smeianov VV, Efimov BA, Kafarskaia LI, Pavlova SI, Shkoporov AN (2012) Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol Immunol 56:27–39
Kleerebezem M, Vaughan EE (2009) Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 63:269–290
Kim NY, Ji GE (2012) Effects of probiotics on the prevention of atopic dermatitis. Korean J Pediatr 55(6):193–201
Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E (2002) Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51–55
Kitaoka M (2012) Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Adv Nutr 3:422S–429S
Kitaoka M, Tian J, Nishimoto M (2005) Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 71:3158–3162
Kobata A (2010) Structures and application of oligosaccharides in human milk. Proc Jpn Acad Ser B Phys Biol Sci 86:731–747
Lee JH, O’Sullivan DJ (2010) Genomic insights into bifidobacteria. Microbiol Mol Biol Rev 74(3):378–416
Lehtoranta L, Kalima K, He L, Lappalainen M, Roivainen M, Narkio M, Makela M, Siitonen S, Korpela R, Pitkaranta A (2014) Specific probiotics and virological findings in symptomatic conscripts attending military service in Finland. J Clin Virol 60(3):276–281
Léké A, Romond MB, Mullié C (2007) Insights in the human bifidobacterial flora through culture-dependent and independent techniques. In: Méndez-Vilas A (ed) Communicating current research and educational topics and trends in Applied Microbiology. Formatex, Badajo, pp 758–765
Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124:e172–e179
Liong MT (2008) Safety of probiotics: translocation and infection. Nutr Rev 66(4):192–202
Lloyd KO, Burchell J, Kudryashov V, Yin BW, Taylor-Papadimitriou J (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem 271:33325–33334
Lönnerdal B (2003) Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 77:1537S–1543S
Makino H, Kushiro A, Ishikawa E, Muylaert D, Kubota H, Sakai T, Oishi K, Martin R, Ben-Amor K, Oozeer R, Knol J, Tanaka R (2011) Transmission of intestinal Bifidobacterium longum subsp. longum strains from mother to infant, determined by multilocus sequencing typing and amplified fragment length polymorphism. Appl Environ Microbiol 77(19):6788–6793
Makino H, Kushiro A, Ishikawa E, Kubota H, Gawad A, Sakai T, Oishi K, Martin R, Ben-Amor K, Knol J, Tanaka R (2013) Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant’s microbiota. PLoS One 8(11):1–10
Mantis NJ, Rol N, Corthésy B (2011) Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4(6):603–611
Martinez FAC, Balciunas EM, Converti A, Cotter PD, De Souza Oliveira RP (2013) Bacteriocin production by Bifidobacterium spp. a review. Biotechnol Adv 31:482–488
Masschalck B, Michiels CW (2003) Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit Rev Microbiol 29:191–214
Matteuzzi D, Crociani F, Zani O, Trovatelli LD (1971) Bifidobacterium suis n. sp.: a new species of the genus Bifidobacterium isolated from pig feces. J Basic Microbiol 11(5):387–395
Ménard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ (2007) Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 74(3):660–666
Meneghin F, Fabiano V, Mameli C, Zuccotti GV (2012) Probiotics and atopic dermatitis in children. Pharmaceuticals 5:727–744
Michail S (2009) The role of probiotics in allergic diseases. Allergy Asthma Clin Immunol 5(5):1–7
Mikami K, Takahashi H, Kimura M, Isozaki M, Izuchi K, Shibata R, Sudo N, Matsumoto H, Koga Y (2009) Influence of maternal bifidobacteria on the establishment of bifidobacteria colonizing the gut in infants. Pediatr Res 65(6):669–674
Mikami K, Kimura M, Takahashi H (2012) Influence of maternal bifidobacteria on the development of gut bifidobacteria in infants. Pharmaceuticals 5:629–642
Milani C, Lugli GA, Duranti S, Turroni F, Bottacini F, Mangifesta M, Sanchez B, Viappiani A, Mancabelli L, Taminiau B, Delcenserie V, Barrangou R, Margolles A, van Sinderen D, Ventura M (2014) Genome encyclopaedia of type strains of the genus Bifidobacterium. Appl Environ Microbiol 80:6290–6302
Mitsuoka T, Kaneuchi C (1977) Ecology of the bifidobacteria. Am J Clin Nutr 30:1799–1810
Morelli L, Patrone V (2014) Probiotic microorganisms for shaping the human gut microbiota – mechanisms and efficacy into the future. In: Tuohy K, Del Rio D (eds) Diet-microbe interactions in the gut: effects on human health and disease. Academic, London, pp 27–39
Moubareck C, Gavini F, Vaugien L, Butel MJ, Doucet-Populaire F (2005) Antimicrobial susceptibility of bifidobacteria. J Antimicrob Chemother 55(1):38–44
Mugie SM, Benninga MA, Lorenzo CD (2011) Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol 25(1):3–18
Namba K, Hatano M, Yaeshima T, Takase M, Suzuki K (2010) Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem 74(5):939–945
Narayan SS, Jalgaonkar S, Shahani S, Kulkarni VN (2010) Probiotics: current trends in the treatment of diarrhea. Hong Kong Med J 16:213–218
Nishimoto M, Kitaoka M (2007a) Identification of the putative proton donor residue of lacto-N-biose phosphorylase (EC 2.4.1.211). Biosci Biotechnol Biochem 71:1587–1591
Nishimoto M, Kitaoka M (2007b) Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl Environ Microbiol 73:6444–6449
Olvera RN, Gutiérrez NA, Azaola EA, Mayorga RL (2013) Characterisation of a Bifidobacterium sp. strain isolated from human faeces and its expression of the ack and ldh genes. Afr J Microbiol Res 7(50):5713–5718
Palframan RJ, Gibson GR, Rastall RA (2003) Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Curr Issues Intest Microbiol 4:71–75
Patole S, Keil AD, Chang A, Nathan E, Doherty D, Simmer K, Esvaran M, Conway P (2014) Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial. PLoS One 9(3):e89511
Philippe D, Favre L, Foata F, Adolfsson O, Perruisseau-Carrier G, Vidal K, Reuteler G, Dayer-Schneider J, Mueller C, Blum S (2011) Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World J Gastroenterol 17(4):459–469
Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C (2005) Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment Pharmacol Ther 22:495–512
Podolsky DK (1985) Oligosaccharide structures of human colonic mucin. J Biol Chem 260:8262–8271
Pokusaeva K, Fitzgerald GF, van Sinderen D (2011) Carbohydrate metabolism in Bifidobacteria. Genes Nutr 6:285–306
Putignani L, Del Chierico F, Petrucca A, Vernocchi P, Dallapiccola B (2014) The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res 76:2–10
Rada V, Splichal I, Rockova S, Grmanova M, Vlkova E (2010) Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains. Biotechnol Lett 32:451–455
Riera CM, Maccioni M, Sotomayor CE (2003) The role of the immune system. In: Fuller R, Perdigón G (eds) Gut flora, nutrition, immunity and health. Blackwell, Great Britain, pp 99–136
Rigottier-Gois L (2013) Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J 7:1256–1261
Ritchie ML, Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7(4), e34938
Ročková Š, Rada V, Havlik J, Švejstil R, Vlková E, Bunešová V, Janda K, Profousová I (2013) Growth of bifidobacteria in mammalian milk. Czech J Anim Sci 58:99–105
Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL (2010) Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156:3329–3341
Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A (2015) The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. BioMed Res Int 2015:505878. doi:10.1155/2015/505878
Salari P, Nikfar S, Abdollahi M (2012) A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy 11:3–14
Sam I-C, Abdul-Murad A, Karunakaran R, Rampal S, Chan Y-F, Nathan AM, Ariffin H (2010) Clinical features of Malaysian children hospitalized with community-acquired seasonal influenza. Int J Infect Dis 14S:e36–e40
Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Solano-Aguilar G, Vaughan E (2010) Safety assessment of probiotics for human use. Gut Microorgan 1(3):164–185
Sani MN, Khodadad A, Fallahi GH, Farahmand F, Motamed F, Sobhani M (2008) Inflammatory bowel disease in infancy. Govaresh 13(1):48–53
Sartor RB, Mazmanlan SK (2012) Intestinal microbes in inflammatory bowel diseases. Am J Gastroenterol Suppl 1:15–21
Sato T, Iino T (2010) Genetic analyses of the antibiotic resistance of Bifidobacterium bifidum strain Yakult YIT 4007. Int J Food Microbiol 137(2–3):254–258
Satoh Y, Shinohara K, Umezaki H, Umezaki H, Shoji H, Satoh H, Ohtsuka Y, Shiga S, Nagata S, Shimizu T, Yamashiro Y (2007) Bifidobacteria prevents necrotizing enterocolitis and infection in preterm infants. Int J Probiotics Prebiotics 2:149–154
Sekirov I, Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Am Physiol Soc 90:859–904
Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, Zwahlen M-C, Desiere F, Bork P, Delley M, Pridmore RD, Arigoni F (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA 99(22):14422–14427
Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163–189
Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, Ziegler PK, Varga J, Reindl W, Pommerenke C, Salinas-Riester G, Böck A, Alpert C, Blaunt M, Polson SC, Brandl L, Kirchner T, Greten FR, Polson SW, Arkan MC (2014) High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 514:508–514
Sela DA, Mills DA (2011) Nursing our microbiota molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol 18:298–307
Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, Price NP, Richardson PM, Mills DA (2008) The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. PNAS 105(48):18964–18969
Shu Q, Qu F, Gill HS (2001) Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr 33(2):171–177
Simonsen L, Viboud C, Taylor RJ, Miller MA (2011) The epidemiology of influenza and its control. In: Del Giudice G, Rappuoli R (eds) Influenza vaccines for the future, 2nd edn, Birkhauser advances in infectious diseases series. Springer, London, pp 27–54
Sjögren YM, Jenmalm MC, Böttcher MF, Björkstén B, Sverremark-Ekström E (2009) Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 39:518–526
Solis G, de los Reyes-Gavilan CG, Fernández N, Margolles A, Gueimonde M (2010) Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut. Anaerobe 16:307–310
Stone KD (2003) Atopic diseases of childhood. Curr Opin Pediatr 14(5):634–646
Suzuki R, Wada J, Katayama T, Fushinobu S, Wakagi T, Shoun H, Sugimoto H, Tanaka A, Kumagai H, Ashida H, Kitaoka M, Yamamoto K (2008) Structural and thermodynamic analyses of solute-binding protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I. J Biol Chem 283:13165–13173
Szajewska H (2012) Human studies on probiotics: infants and children. In: Lahtinen S, Ouwehand AC, Salminen S, von Wright A (eds) Lactic acid bacteria. CRC Press, Boca Raton, FL, pp 525–541
Szczawinska-Poplonyk A (2012) Development of mucosal immunity in children: a rationale for sublingual immunotherapy? J Allergy. doi:10.1155/2012/492761
Tabbers MM, de Milliano I, Roseboom MG, Benninga MA (2011) Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study. Nutr J 10(19):1–5
Taipale T, Pienihäkkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P, Jokela J, Söderling E (2011) Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 105:409–416
Taniuchi S, Hattori K, Yamamoto A, Sasai M, Hatano Y, Kojima T, Kobayashi Y, Iwamoto H, Yaeshima T (2005) Administration of Bifidobacterium to infants with atopic dermatitis: changes in fecal microflora and clinical symptoms. J Appl Res 5:387–396
Tannock GW (1999) Identification of Lactobacilli and Bifidobacteria. Curr Issues Mol Biol 1(1):53–64
Toh ZQ, Anzela A, Tang MLK, Licciardi PV (2012) Probiotic therapy as a novel approach for allergic disease. Front Pharmacol 3(171):1–14
Tomosada Y, Villena J, Murata K, Chiba E, Shimazu T, Aso H, Iwabuchi N, Xiao JZ, Saito T, Kitazawa H (2013) Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS One 8, e59259
Tregoning JS, Schwarze J (2010) Respiratory viral infections in infants: causes, clinical symptoms, virology and immunology. Clin Microbiol Rev 23(1):74–98
Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, Zomer A, Sánchez B, Bidossi A, Ferrarini A, Giubellini V, Delledonne M, Henrissat B, Coutinho P, Oggioni M, Fitzgerald GF, Mills D, Margolles A, Kelly B, van Sinderen D, Ventura M (2010) Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. PNAS 107(45):19514–19519
Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, Kerr C, Hourihane J, Murray D, Fuligni F, Gueimonde M, Margolles A, De Bellis G, O’Toole PW, Van Sinderen D, Marchesi JR, Ventura M (2012) Diversity of bifidobacteria within the infant gut microbiota. PLoS One 7(5):1–12
Turroni F, Duranti S, Bottacini F, Guglielmetti S, Van Sinderen D, Ventura M (2014) Bifidobacterium bifidum as an example of a specialized human gut commensal. Front Microbiol 5(437):1–8
Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, Tancredi DJ, Mills DA (2013) A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr 163:1585–1591
Urashima T, Asakuma S, Leo F, Fukuda K, Messer M, Oftedal OT (2012) The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv Nutr 3:473S–482S
Uslu N, Usta Y, Balamtekin N, Demir H, Saltik-Temizel IN, Yüce A (2009) Inflammatory bowel disease in infancy. Indian J Gastroenterol 28(6):224–226
van der Aa LB, Heymans HS, van Aalderen WM, Sillevis Smitt JH, Knol J, Ben Amor K, Goossens DA, Sprikkelman AB (2010) Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clin Exp Allergy 40:795–804
van der Aa LB, van Aalderen WM, Heymans HS, Henk Sillevis Smitt J, Nauta AJ, Knippels LM, Ben Amor K, Sprikkelman AB (2011) Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 66:170–177
Vebø HC, Sekelja M, Nestestog R, Storrø O, Johnsen R, Øien T, Rudi K (2011) Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant array. Clin Vaccine Immunol 18(8):1326–1335
Ventura M, Turroni F, van Sinderen D (2012a) Bifidobacteria: general overview on ecology, taxanomy, and genomics. In: Salminen S, von Wright A, Lahtinen S, Ouwehand A (eds) Lactic acid bacteria: microbiological and functional aspects, 4th edn. CRC Press, Boca Raton, FL, pp 147–164
Ventura M, Turroni F, Motherway MO, MacSharry J, van Sinderen D (2012b) Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. Trends Microbiol 20(10):467–476
Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME (2008) Probiotics for the prevention of respiratory tract infections: a systemic review. Int J Antimicrob Agents 34:197.e1–197.e10
Vouloumanou EK, Makris GC, Karageogopoulos DE, Falagas ME (2009) Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents 343:e191–e110
Wada J, Suzuki R, Fushinobu S, Kitaoka M, Wakagi T, Shoun H, Ashida H, Kumagai H, Katayama T, Yamamoto K (2007) Purification, crystallization and preliminary X-ray analysis of the galacto-N-biose-/lacto-N-biose I-binding protein (GL-BP) of the ABC transporter from Bifidobacterium longum JCM1217. Acta Crystallogr 63:751–753
Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M, Kumagai H, Katayama T, Yamamoto K (2008) Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 74:3996–4004
Walker CL, Perin J, Aryee MJ, Boshi-Pinto C, Black RE (2012) Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health 12(220):1–7
Ward RE, Niñonuevo M, Mills DA, Lebrilla CB, German JB (2007) In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res 51:1398–1405
Wasilewska E, Bielecka M, Markiewicz L (2003) Numerical analysis of biochemical and morphological features of bifidobacteria as a tool for species characteristic and identification. Polish J Food Nutr Sci 12(53):149–156
Weber TK, Polanco I (2012) Gastrointestinal microbiota and some children diseases: a review. Gastroenterol Res Pract. doi:10.1155/2012/676585
Weizman Z, Asli G, Alsheikh A (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115:5–9
World Gastroenterology Organisation (2008) Probiotics and prebiotics. World Gastroenterology Organisation Practice Guideline 1–22
Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Togashi H, Enomoto K, Enomoto T (2006) Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy 36:1425–1435
Xiao JZ, Kondo S, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Enomoto T (2007) Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development. Int Arch Allergy Immunol 144(2):123–127
Xiao J, Takahashi S, Nishimoto M, Odamaki T, Yaeshima T, Iwatsuki K, Kitaoka M (2010) Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Appl Environ Microbiol 76:54–59
Yeşilova Y, Çalka Ö, Akdeniz N, Berktaş M (2012) Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 24(2):189–193
Yoshida Y, Seki T, Matsunaka H, Watanabe T, Shindo M, Yamada N, Yamamoto O (2010) Clinical effects of probiotic Bifidobacterium breve supplementation in adult patients with atopic dermatitis. Yonago Acta Med 53:37–45
Acknowledgment
This work was supported by the grant (304/PTEKIND/650689) provided by Morinaga Milk Industry Co., Ltd.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lau, A.SY., Xiao, JZ., Liong, MT. (2015). Bifidobacterium for Infants: Essence and Efficacy. In: Liong, MT. (eds) Beneficial Microorganisms in Medical and Health Applications. Microbiology Monographs, vol 28. Springer, Cham. https://doi.org/10.1007/978-3-319-23213-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-23213-3_3
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23212-6
Online ISBN: 978-3-319-23213-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)